EyePoint completes enrollment in second phase 3 trial of sustained-release AMD therapy
ByJay S. Duker, MD ByAlex Young ByAnthony DeFino Fact checked by Christine Klimanskis, ELS Key takeaways: More than 400 patients have been enrolled in the LUCIA trial investigating Duravyu. EyePoint…